Presentation on the regulatory support for ATMPs development in Spain at EuroGCT Lunchtime Symposium during the ESGCT Congress, 10 October 2025, Sevilla, Spain.
The EuroGCT Lunchtime Symposium provides an overview and discusses with policy- and law-makers, and regulators, the policy strategies at stake and their current and prospective impact on the regulation of gene and cell therapy in Europe.
Presentation:
Support for ATMPs development in Spain: the (central) role of the Spanish Medicines Agency (AEMPS)
Speaker:
Marcos Timon, The Spanish Agency of Medicines and Medical Devices (AEMPS)
Please download and view the PDF file of this presentation from the attachment section below.